Astria Therapeutics Inc. buy BiotechBee
Start price
20.07.23
/
60%
€8.86
Target price
30.04.26
€10.00
Performance (%)
3.84%
End price
14.12.24
€9.20
Summary
This prediction ended on 14.12.24 with a price of €9.20. With a performance of 3.84%, the BUY prediction by BiotechBee for Astria Therapeutics Inc. closed with a slight gain. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Astria Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% |
According to BiotechBee what are the pros and cons of Astria Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Astria Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Astria Therapeutics Inc.
Buy beendet

